Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104177336A details efficient asymmetric oxidation for Dexlansoprazole. Achieve high optical purity and cost reduction in pharma manufacturing.
Patent CN1197837C details a scalable Wittig-Horner route for C15 and C20 polyenoid units. Achieve cost reduction in fine chemical manufacturing via catalytic oxidation.
Patent CN1871230A reveals a high-yield catalytic oxidation route for heliotropine. Discover cost-effective manufacturing and supply chain advantages for fine chemicals.
Patent CN1241890C reveals a scalable 3-step route for C10 dialdehyde monoacetals, offering safer reduction and catalytic oxidation for carotenoid manufacturing.
Patent CN101255128A offers a chlorosulfonic acid-free route for high-purity para-ester. This method ensures supply chain stability and cost reduction in dye intermediate manufacturing.
Novel oxidation-reduction process for high-purity 4-(sulfonylphenyl)piperidines. Reduces steps and improves yield for CNS drug intermediates.
Patent CN104327073B details a safer semi-synthetic route for Vinpocetine, eliminating column chromatography to ensure high purity and cost reduction in API manufacturing.
Patent CN112225705B reveals a green V2O5-catalyzed oxidation route for sulfentrazone intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Advanced synthesis of p-methylsulfonyl benzaldehyde via nucleophilic substitution and oxidation. High yield, low cost route for reliable pharmaceutical intermediate supply.
Novel low-temperature route for erlotinib intermediates eliminates noble metals. Reduces costs and improves supply chain stability for API manufacturing.
Patent CN110746428A details a novel asymmetric oxidation route for high-purity R-type chiral sulfoxide, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN101928193A details a CoSalen-catalyzed oxidation method for high-purity symmetrical disulfides, offering cost-effective and scalable solutions for pharma intermediates.
Novel FeCl3-TEMPO oxidation method enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing significantly.
Patent CN115772143B reveals a green Bi-Pt catalytic method for FDCA synthesis eliminating alkaline waste and reducing processing complexity for bio-based polymer manufacturers.
Novel FeCl3 catalytic oxidation method for galanthamine intermediates offers mild conditions and high yield for pharmaceutical supply chains.
Patent CN1729196A details a high-yield asymmetric oxidation process for neurokinin antagonists, offering cost-effective manufacturing solutions.
Patent CN111848508A details a green catalytic oxidation method for quinolines using copper and oxygen, offering cost-effective and scalable solutions for pharmaceutical intermediates.
Novel patent CN105001114B offers high-purity Iopromide preparation. Reduces by-products and simplifies supply chain for contrast agent manufacturing.
Patent CN118580187A reveals green chlorophyll photocatalysis for dihydroisoquinolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1243717C details a one-step oxidative method for o-nitrobenzaldehyde using metalloporphyrins. Offers cost-effective, scalable production for pharmaceutical intermediates.